Stech Marlitt, Quast Robert B, Sachse Rita, Schulze Corina, Wüstenhagen Doreen A, Kubick Stefan
Fraunhofer Institute for Biomedical Engineering (IBMT), Branch Potsdam-Golm, Potsdam, Germany.
Beuth Hochschule für Technik Berlin - University of Applied Sciences Berlin, Life Sciences and Technology, Berlin, Germany.
PLoS One. 2014 May 7;9(5):e96635. doi: 10.1371/journal.pone.0096635. eCollection 2014.
In this study, we present a novel technique for the synthesis of complex prokaryotic and eukaryotic proteins by using a continuous-exchange cell-free (CECF) protein synthesis system based on extracts from cultured insect cells. Our approach consists of two basic elements: First, protein synthesis is performed in insect cell lysates which harbor endogenous microsomal vesicles, enabling a translocation of de novo synthesized target proteins into the lumen of the insect vesicles or, in the case of membrane proteins, their embedding into a natural membrane scaffold. Second, cell-free reactions are performed in a two chamber dialysis device for 48 h. The combination of the eukaryotic cell-free translation system based on insect cell extracts and the CECF translation system results in significantly prolonged reaction life times and increased protein yields compared to conventional batch reactions. In this context, we demonstrate the synthesis of various representative model proteins, among them cytosolic proteins, pharmacological relevant membrane proteins and glycosylated proteins in an endotoxin-free environment. Furthermore, the cell-free system used in this study is well-suited for the synthesis of biologically active tissue-type-plasminogen activator, a complex eukaryotic protein harboring multiple disulfide bonds.
在本研究中,我们提出了一种新技术,通过使用基于培养昆虫细胞提取物的连续交换无细胞(CECF)蛋白质合成系统来合成复杂的原核和真核蛋白质。我们的方法由两个基本要素组成:第一,在含有内源性微粒体囊泡的昆虫细胞裂解物中进行蛋白质合成,这使得新合成的目标蛋白质能够转运到昆虫囊泡腔内,或者对于膜蛋白而言,能够嵌入天然膜支架中。第二,无细胞反应在两室透析装置中进行48小时。与传统的分批反应相比,基于昆虫细胞提取物的真核无细胞翻译系统和CECF翻译系统的结合导致反应寿命显著延长,蛋白质产量增加。在此背景下,我们展示了各种代表性模型蛋白质的合成,其中包括胞质蛋白、与药理学相关的膜蛋白以及在内毒素-free环境中的糖基化蛋白。此外,本研究中使用的无细胞系统非常适合合成具有生物活性的组织型纤溶酶原激活剂,这是一种含有多个二硫键的复杂真核蛋白质。